Consistently, we also confirmed their interaction in HCC cell lines, and overexpression of Siah-1 markedly shortened the half-life of Myd88 and induced its polyubiquitination and subsequent degradation, which can be blocked by the proteasome inhibitor MG132. Here, MYD88 is linked to hepatocellular carcinoma.